Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma
Carcinogenesis and Chemotherapy · 2024
DOI: 10.31579/2835-9216/017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis and Chemotherapy, 2024. Verfasst von Andrew Hague.
Abstract (Originalsprache)
Use of the Cellsonic VIPP in the treatment of stage IV choriocarcinoma following two courses of chemotherapy appears to halt and reverse cancer markers and tumor volume in a 43-year-old male patient.
Zitieren
APA
Hague, A. (2024). Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma. Carcinogenesis and Chemotherapy. https://doi.org/10.31579/2835-9216/017
Vancouver
Hague A. Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma. Carcinogenesis and Chemotherapy. 2024. doi:10.31579/2835-9216/017
BibTeX
@article{Hague2024,
author = {Hague, Andrew},
title = {Reduced Tumor Mass, Reduction and Stabilization of Cancer Markers, Through Adjunct Use of CellSonic VIPP in the Treatment of Stage IV Choriocarcinoma},
journal = {Carcinogenesis and Chemotherapy},
year = {2024},
doi = {10.31579/2835-9216/017}
}
EUVIMED